Novartis AG is 38.7x more valuable than Alkermes plc. by market capitalization ($282.64 B vs $7.31 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALKS | NVS |
|---|---|---|
| Market cap | $7.31 B | $282.64 B |
| US-listed rank | #1123 | #47 |
| Revenue (latest FY) | $1.48B | - |
| Net income (latest FY) | $241.70M | - |
| Net margin | 16.4% | - |
| P/E (trailing FY) | 30.2 | - |
| SEC filings | 1,884 | 947 |
Novartis AG is 38.7x more valuable than Alkermes plc. by market capitalization ($282.64 B vs $7.31 B).
Full pages: Alkermes plc. and Novartis AG, or browse the full rankings.